Herbas VPB

Print
EN | LT
LT - Hepatinės encefalopatijos gydymas rifaksiminu
EN - TREATMENT OF HEPATIC ENCEPHALOPATHY USING RIFAXIMIN

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/437 (2006.01)
A61K 45/06 (2006.01)
A61K 31/08 (2006.01)
A61K 31/352 (2006.01)
A61K 31/4164 (2006.01)
A61K 31/426 (2006.01)
A61K 31/4439 (2006.01)
A61K 31/606 (2006.01)
A61K 31/7016 (2006.01)
A61K 31/785 (2006.01)
A61K 38/14 (2006.01)
A61K 38/31 (2006.01)
A61P 1/16 (2006.01)
A61K 31/395 (2006.01)
European patent
(11) Number of the document 3628319
(13) Kind of document T
(96) European patent application number 19207534.9
Date of filing the European patent application 2009-10-02
(97) Date of publication of the European application 2020-04-01
(45) Date of publication and mention of the grant of the patent 2024-02-14
(46) Date of publication of the claims translation 2024-03-25
Priority applications
(30) Number Date Country code
102349 P 2008-10-02 US
Inventors
(72)
FORBES, William , US
Grantee
(73) Salix Pharmaceuticals, Inc. , 8450 Colonnade Center Drive, Colonnade 1, Raleigh, NC 27615, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Hepatinės encefalopatijos gydymas rifaksiminu
  TREATMENT OF HEPATIC ENCEPHALOPATHY USING RIFAXIMIN
Last renewal fee
Payment date Validity (years) Amount
2024-08-23 16 347.00 EUR
Next renewal fee
2025-10-02